about
Effects of moxonidine on sympathetic nervous system activity: An update on metabolism, cardio, and other target-organ protectionSpontaneous pneumomediastinum may be associated with both anorexia nervosa and obesityDiabetes mellitus and cerebrovascular disease: which are the actual data?Acute renal failure caused by leptospirosis and Hantavirus infection in an urban hospital.Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura.Is there a role for low-dose eltrombopag as maintenance therapy in the treatment of immune thrombocytopenia?Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.Ceruloplasmin is a better predictor of the long-term prognosis compared with fibrinogen, CRP, and IL-6 in patients with severe unstable angina.The role of uric acid in stroke: the issue remains unresolved.Neuropeptide Y and alpha-melanocyte-stimulating hormone: interaction in obesity and possible role in the development of hypertension.The role of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.Rate of suicide and suicide attempts and their relationship to unemployment in Thessaloniki Greece (2000-2012).Are we getting to lipid targets in real life?Riedel's lobe of the liver: a case report.Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.Advanced glycosylation end products and nutrition--a possible relation with diabetic atherosclerosis and how to prevent it.Vitamins and stroke: the homocysteine hypothesis still in doubt.Malnutrition in end stage liver disease: recommendations and nutritional support.The neuroprotective role of erythropoietin in the management of acute ischaemic stroke: from bench to bedside.Implementation of guidelines for the management of arterial hypertension. The impulsion studyIs the anti-hypertensive effect of dietary supplements via aldehydes reduction evidence based? A systematic review.The syndrome of rhabdomyolysis: complications and treatment.Association between nonalcoholic fatty liver disease and acute ischemic stroke severity and outcome.The controversial role of B-vitamins in cardiovascular risk: An update.Effect of HMG-CoA reductase inhibitors on vascular cell apoptosis: beneficial or detrimental?Risk factors and drug interactions predisposing to statin-induced myopathy: implications for risk assessment, prevention and treatment.Insulin-sensitizing agents in the treatment of polycystic ovary syndrome: an update.Role of phytosterols in lipid-lowering: current perspectives.Adipokines and stroke: a review of the literature.Age, weight and obesity.Hypovitaminosis D and peripheral arterial disease: emerging link beyond cardiovascular risk factors.Acupuncture in the treatment of obesity: a narrative review of the literature.Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids.Initially lymphocytic Sweet's syndrome in male patients with myelodysplasia: a distinguished clinicopathological entity? Case report and systematic review of the literature.Is anemia a new cardiovascular risk factor?Parasuicidal poisoning treated in a Greek medical ward: epidemiology and clinical experience.Simultaneous manifestation of pleural effusion and acute renal failure associated with dasatinib: a case report.Hypokalemia induced myopathy as first manifestation of primary hyperaldosteronism - an elderly patient with unilateral adrenal hyperplasia: a case report.Predictive value of the ankle brachial index in patients with acute ischemic stroke.Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients.
P50
Q27002648-173BCDA4-8B39-4D92-B31E-44642CFCD26DQ28251656-79764FC5-8F40-469D-B4FE-FF861FF341F2Q31150339-60C68C69-8379-4F06-9F15-95F19F7A1B33Q33342869-A147AC84-B69A-4AC3-BAE3-5D10B12CE633Q33379782-01808CCF-C114-4E22-877A-D0EA77B5B99CQ33417399-8A113F4F-5D90-49BE-BDC2-AC2857986A77Q33708384-F4676BC3-4B20-4BF3-B483-80C309434168Q34767602-70C01DAA-6C0D-47F2-8586-96DC6037863CQ34794610-C7E420D6-EF72-4446-8E6F-E41E77B813B7Q34827652-A5B52FA9-19DC-4217-B667-13F4890E37B1Q34994296-877011F4-94E1-48B9-B7FF-95A7D928A878Q35511864-97BF2CF4-0B32-4DA4-BF52-AD02D57C4669Q35817670-B87C7844-71F0-403E-A54C-818F97BA8010Q36151906-3CA0684E-6579-46A2-9389-9E38EC65961BQ36755797-EFF15E32-E00F-46A9-8F61-A9A42309AECFQ36997980-625DDE5F-A202-42D2-AD80-FA68B7EB09A3Q37057242-E8AE13F7-D641-4BF7-9BFC-736AC73CD482Q37132386-84AE0E1D-7FE6-417A-A2C4-20BD941945B9Q37177533-49A99ECC-ED77-43DE-91B7-4092A2155011Q37239716-5280B19A-C24C-45BD-8D27-755F11C96BCBQ37293954-92CB6A92-838A-49EA-BB97-25B8796D7808Q37338552-090AD4FF-CFFF-4129-8748-A442729B0F3AQ37358279-C077956F-B880-4466-8550-62A1DCBD9D58Q37645062-1D602A49-794B-4CA1-B8B6-EF3074D65EFCQ37671164-E3DAC9C7-5D1D-4330-B9FB-CBE9F4269480Q37693135-043E2B0F-D74E-4E39-8821-98F35F9FF5BCQ37781266-18607F1F-F020-4231-86E0-14F51B6E5794Q37843096-75D0ADE9-1910-4514-BA7A-93226861D7CCQ37940717-8B96CB13-5B3A-47E1-82A4-C6D0A03C42E9Q37973980-0ED66F4A-7083-4F36-909F-309A3835E15EQ38029815-B2E19990-C03C-48A2-B144-83B9B688EF6EQ38059919-CC607926-FC30-4514-B408-4621CA9B7FDBQ38154668-A0CEC55A-A2E7-446D-9CF0-2D92B91D93A9Q38203141-D2E149AE-EC00-495D-A94C-6216F8CB5621Q38392875-2A8FB9B7-8442-4169-B653-A253A78A7C01Q39598874-166BD1C1-03FC-43AA-9300-4A416D378F13Q40229471-A6D38F84-C006-4A04-BFB7-E03B3833E24DQ41906204-B487BE1F-A91B-4D30-8D3A-6404C6DDCB23Q43635855-EE48684A-19BB-460A-9FF8-47DBE634CB0BQ44024408-3B0AC4F1-688D-46FF-8D0A-A6DEC844D4E1
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Apostolos I. Hatzitolios
@ast
Apostolos I. Hatzitolios
@en
Apostolos I. Hatzitolios
@es
Apostolos I. Hatzitolios
@nl
Apostolos I. Hatzitolios
@sl
type
label
Apostolos I. Hatzitolios
@ast
Apostolos I. Hatzitolios
@en
Apostolos I. Hatzitolios
@es
Apostolos I. Hatzitolios
@nl
Apostolos I. Hatzitolios
@sl
prefLabel
Apostolos I. Hatzitolios
@ast
Apostolos I. Hatzitolios
@en
Apostolos I. Hatzitolios
@es
Apostolos I. Hatzitolios
@nl
Apostolos I. Hatzitolios
@sl
P106
P1153
26643224700
P21
P31
P496
0000-0002-2323-8594